Evidence map›Paper›PMID 20473272›Full record

ArticleThe EMBO journal2010

The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation.

Jiangbin Ye, Monika Kumanova, Lori S Hart, Kelly Sloane, Haiyan Zhang, Diego N De Panis, Ekaterina Bobrovnikova-Marjon, J Alan Diehl, David Ron, Constantinos Koumenis

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 478 papers.

0numbers the graph read from it
0cells of the map it votes in
478citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

478 citing papers in PubMed, 692 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Suppression rather than activation of the integrated stress response (GCN2-ATF4) pathway extends lifespan in the fly.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  15. A Novel Potent and Selective GCN2 Inhibitor, APL-4098, Has Antileukemic Activity through Dysregulation of Mitochondrial Function.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  16. Review
  17. Article
  18. Dissecting Complex Interactions Between Ferroptosis and the Proteasome.bioRxiv : the preprint server for biology · 2026
    Article
  19. Article
  20. Article

418 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jiangbin YeDepartment of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Monika Kumanova
Lori S Hart
Kelly Sloane
Haiyan Zhang
Diego N De Panis
Ekaterina Bobrovnikova-Marjon
J Alan Diehl
David Ron
Constantinos Koumenis
University of Pennsylvania · USCancer Research Institute · USNew York University · US

Funding

TRANSLATIONAL CONTROL IN ADAPTATION TO HYPOXIAP01CA104838 · NCI · UNIVERSITY OF PENNSYLVANIA · PI DIEHL, JOHN ALAN · 2004 to 2018
$17.6M
THE CELLULAR RESPONSE TO NON-MUTAGENIC CARCINOGENSR01ES008681 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FISHMAN, GLENN I · 1996 to 2010
$4.4M
Role of elF2a phosphorylation and ER stress in hypoxia tolerance and tumor growthR01CA094214 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KOUMENIS, CONSTANTINOS · 2002 to 2016
$3.6M
Metabolic Regulation in the Acute PhaseR37DK047119 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RON, DAVID · 2003 to 2009
$3.0M
METABOLIC REGULATION IN THE ACUTE PHASER01DK047119 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RYOO, HYUNG D · 1999 to 2010
$1.5M
METABOLIC REGULATION IN THE ACUTE-PHASE RESPONSER29DK047119 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RON, DAVID · 1993 to 1997
–
Medical Research Council G0600717NCI NIH HHS CA94214NCI NIH HHS P01 CA104838NCI NIH HHS R01 CA094214NIDDK NIH HHS DK47119NIDDK NIH HHS R01 DK047119NIDDK NIH HHS R37 DK047119NIEHS NIH HHS ES08681NIEHS NIH HHS R01 ES008681
6 · The paper itself

Abstract

The transcription factor ATF4 regulates the expression of genes involved in amino acid metabolism, redox homeostasis and ER stress responses, and it is overexpressed in human solid tumours, suggesting that it has an important function in tumour progression. Here, we report that inhibition of ATF4 expression blocked proliferation and survival of transformed cells, despite an initial activation of cytoprotective macroautophagy. Knockdown of ATF4 significantly reduced the levels of asparagine synthetase (ASNS) and overexpression of ASNS or supplementation of asparagine in trans, reversed the proliferation block and increased survival in ATF4 knockdown cells. Both amino acid and glucose deprivation, stresses found in solid tumours, activated the upstream eukaryotic initiation factor 2alpha (eIF2alpha) kinase GCN2 to upregulate ATF4 target genes involved in amino acid synthesis and transport. GCN2 activation/overexpression and increased phospho-eIF2alpha were observed in human and mouse tumours compared with normal tissues and abrogation of ATF4 or GCN2 expression significantly inhibited tumour growth in vivo. We conclude that the GCN2-eIF2alpha-ATF4 pathway is critical for maintaining metabolic homeostasis in tumour cells, making it a novel and attractive target for anti-tumour approaches.

Indexed as

Activating Transcription Factor 4Amino AcidsAnimalsCell ProliferationCell SurvivalCulture MediaGene Knockdown TechniquesGlucoseHumansMiceProtein Serine-Threonine KinasesActivating Transcription Factor 4Amino AcidsATF4 protein, humanAtf4 protein, mouseCulture MediaEIF2AK4 protein, humanEif2ak4 protein, mouseGlucoseProtein Serine-Threonine Kinases

Identifiers

PMID20473272
PMCPMC2892366
OpenAlexW2166063624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.